Chen, Cheng-Pin <br/><br/>
Evaluation of cost-effectiveness of peginterferon plus ribavirin for chronic hepatitis C treatment and direct-acting antiviral agents among HIV-infected patients in the prison and community settings.  [electronic resource] 

 -  Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi  Aug 2019 
 - 556-562 p.  digital 
<br/><br/> Publication Type: Journal Article; Observational Study 
<br/><br/><label>ISSN: </label>1995-9133 
<br/><br/><label>Standard No.: </label>10.1016/j.jmii.2018.10.002  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antiviral Agents--economics<br/>Coinfection--drug therapy<br/>Cost-Benefit Analysis<br/>Drug Therapy, Combination--economics<br/>Female<br/>Genotype<br/>HIV Infections--complications<br/>Health Care Costs<br/>Hepatitis C, Chronic--complications<br/>Humans<br/>Male<br/>Middle Aged<br/>Prisons<br/>Retrospective Studies<br/>Ribavirin--economics<br/>Taiwan<br/>Viral Load